Concepedia

Roy M. Gulick

RM

Statistics

Publications

132

Citations

15.9K

H-Index

58

Active since

1989

Affiliations

Cornell University(Current)

Harvard University

University of North Carolina at Chapel Hill

Weill Cornell Medicine

Brigham and Women's Hospital

Roy M. Gulick is an author at Cornell University specializing in antiretroviral therapy, antiviral therapy, and hiv antiretroviral therapy.

Publications per year

1989–2024

132

Publications

132

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 853 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Marina Caskey, Florian Klein, Julio C. C. Lorenzi et al. · Nature · 2015 · 774 citations

Life Sciences, Immunology, Infectious Diseases +12

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W. Haas, Heather J. Ribaudo, Richard B. Kim et al. · PubMed · 2004 · 629 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 132